Is Zentalis Pharmaceuticals, Inc. (ZNTL) a Buy, Sell, or Hold?
NASDAQ : ZNTL
Zentalis Pharmaceuticals, Inc. — Insider Trades
$4.22 USD
-$0.78 (-15.6%)
- Volume
- 1.58M
- Average Volume
- 1.17M
- Market Capitalization
- $300.41M
- P/E Ratio
- -1.72
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $6.95
- Year Low
- $1.21
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.82
Insider Activity Summary (Last 12 Months)
Insiders Buying
12
Insiders Selling
10
Amount of Insider Selling
$7.56M
ZNTL Insider Buying/Selling by Quarter
ZNTL Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Johnson David Michael | director | 2026-06-16 | A-Award | 0 | 2026-06-18 |
| Skvarka Jan | director | 2026-06-16 | A-Award | 0 | 2026-06-18 |
| Walker Luke Nathaniel | director | 2026-06-16 | A-Award | 0 | 2026-06-18 |
| Kariuki Enoch | director | 2026-06-16 | A-Award | 0 | 2026-06-18 |
| Myers Scott Dunseth | director | 2026-06-16 | A-Award | 0 | 2026-06-18 |
| Campbell Shannon | director | 2026-05-26 | A-Award | 0 | 2026-05-27 |
| Campbell Shannon | director: | 2026-05-22 | 0 | 2026-05-27 | |
| Bruns Ingmar | officer: Chief Medical Officer | 2026-02-06 | S-Sale | 2.4297 | 2026-02-10 |
| Bruns Ingmar | officer: Chief Medical Officer | 2026-02-09 | S-Sale | 2.3929 | 2026-02-10 |
| Vultaggio Vincent | officer: PAO and PFO | 2026-02-06 | S-Sale | 2.4297 | 2026-02-10 |
| Vultaggio Vincent | officer: PAO and PFO | 2026-02-09 | S-Sale | 2.3929 | 2026-02-10 |
| Vultaggio Vincent | officer: PAO and PFO | 2026-02-10 | S-Sale | 2.4223 | 2026-02-10 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | 2026-02-06 | S-Sale | 2.4297 | 2026-02-10 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | 2026-02-09 | S-Sale | 2.3929 | 2026-02-10 |
| Vultaggio Vincent | officer: PAO and PFO | 2026-02-02 | S-Sale | 2.55 | 2026-02-04 |
| Vultaggio Vincent | officer: PAO and PFO | 2026-02-03 | S-Sale | 2.515 | 2026-02-04 |
| Vultaggio Vincent | officer: PAO and PFO | 2026-01-08 | A-Award | 2.84 | 2026-01-09 |
| Bucher James B | officer: Chief Legal Officer | 2026-01-08 | A-Award | 2.84 | 2026-01-09 |
| Bruns Ingmar | officer: Chief Medical Officer | 2026-01-08 | A-Award | 2.84 | 2026-01-09 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | 2026-01-08 | A-Award | 2.84 | 2026-01-09 |
| WALTERS GROUP | 10 percent owner | 2025-12-31 | P-Purchase | 1.2 | 2026-01-08 |
| WALTERS GROUP | 10 percent owner | 2025-12-15 | 0 | 2026-01-08 | |
| Matrix Capital Management Company, LP | 10 percent owner | 2025-12-15 | S-Sale | 1.33 | 2025-12-15 |
| Bucher James B | officer: Chief Legal Officer | 2025-10-01 | A-Award | 1.54 | 2025-10-01 |
| Bucher James B | officer | 2025-09-18 | 0 | 2025-09-22 | |
| Walker Luke Nathaniel | director | 2025-06-17 | A-Award | 0 | 2025-06-18 |
| Skvarka Jan | director | 2025-06-17 | A-Award | 0 | 2025-06-18 |
| Johnson David Michael | director | 2025-06-17 | A-Award | 0 | 2025-06-18 |
| Kariuki Enoch | director | 2025-06-17 | A-Award | 0 | 2025-06-18 |
| Myers Scott Dunseth | director | 2025-06-17 | A-Award | 0 | 2025-06-18 |
| Myers Scott Dunseth | director | 2025-04-30 | P-Purchase | 1.3987 | 2025-04-30 |
| Bruns Ingmar | officer: Chief Medical Officer | 2025-02-06 | P-Purchase | 2.2828 | 2025-02-12 |
| Vultaggio Vincent | officer: PAO and Interim PFO | 2025-02-03 | A-Award | 0 | 2025-02-05 |
| Vultaggio Vincent | officer: PAO and Interim PFO | 2025-02-03 | S-Sale | 1.7115 | 2025-02-05 |
| Vultaggio Vincent | officer: PAO and Interim PFO | 2025-02-03 | A-Award | 1.68 | 2025-02-05 |
| Lackner Mark | officer: Chief Scientific Officer | 2025-02-03 | A-Award | 0 | 2025-02-05 |
| Lackner Mark | officer: Chief Scientific Officer | 2025-02-03 | S-Sale | 1.7115 | 2025-02-05 |
| Lackner Mark | officer: Chief Scientific Officer | 2025-02-03 | A-Award | 1.68 | 2025-02-05 |
| Paul Andrea | officer: Chief Legal Officer | 2025-02-03 | A-Award | 0 | 2025-02-05 |
| Paul Andrea | officer: Chief Legal Officer | 2025-02-03 | S-Sale | 1.7115 | 2025-02-05 |
| Paul Andrea | officer: Chief Legal Officer | 2025-02-03 | A-Award | 1.68 | 2025-02-05 |
| Bruns Ingmar | officer: Chief Medical Officer | 2025-02-03 | A-Award | 1.68 | 2025-02-05 |
| Bruns Ingmar | officer: Chief Medical Officer | 2025-02-03 | A-Award | 0 | 2025-02-05 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | 2025-02-03 | A-Award | 0 | 2025-02-05 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | 2025-02-03 | A-Award | 1.68 | 2025-02-05 |
| Skvarka Jan | director | 2025-01-31 | P-Purchase | 1.7241 | 2025-02-04 |
| Walker Luke Nathaniel | director | 2025-01-31 | P-Purchase | 1.7582 | 2025-02-04 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | 2025-01-31 | P-Purchase | 1.7314 | 2025-02-04 |
| Lackner Mark | officer: Chief Scientific Officer | 2025-01-02 | S-Sale | 3.12 | 2025-01-03 |
| Bruns Ingmar | officer: Chief Medical Officer | 2024-12-02 | A-Award | 3.66 | 2024-12-03 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | 2024-12-02 | A-Award | 3.66 | 2024-12-03 |
| Myers Scott Dunseth | director | 2024-11-13 | A-Award | 0 | 2024-11-13 |
| Bruns Ingmar | officer | 2024-11-13 | 0 | 2024-11-13 | |
| EASTLAND JULIA MARIE | director, officer: CEO & President | 2024-11-13 | 0 | 2024-11-13 | |
| Myers Scott Dunseth | director: | 2024-11-13 | 0 | 2024-11-13 | |
| Vultaggio Vincent | officer: Principal Accounting Officer | 2024-10-04 | S-Sale | 3.18 | 2024-10-04 |
| Skvarka Jan | director | 2024-06-21 | A-Award | 0 | 2024-06-21 |
| Kariuki Enoch | director | 2024-06-21 | A-Award | 0 | 2024-06-21 |
| Johnson David Michael | director | 2024-06-21 | A-Award | 0 | 2024-06-21 |
| Gallagher Cam | director, officer: President, Interim CFO | 2024-05-31 | S-Sale | 11.98 | 2024-05-31 |
| Walker Luke Nathaniel | director | 2024-05-24 | A-Award | 0 | 2024-05-29 |
| Walker Luke Nathaniel | director: | 2024-05-24 | 0 | 2024-05-29 | |
| HAUSMAN DIANA | officer: Chief Medical Officer | 2024-05-09 | S-Sale | 12.62 | 2024-05-09 |
| Vultaggio Vincent | officer: Principal Accounting Officer | 2024-04-05 | 0 | 2024-04-11 | |
| Vultaggio Vincent | officer: Principal Accounting Officer | 2024-04-05 | 18 | 2024-04-11 | |
| Vultaggio Vincent | officer: Principal Accounting Officer | 2024-04-05 | 42.04 | 2024-04-11 | |
| Vultaggio Vincent | officer: Principal Accounting Officer | 2024-04-05 | 47.66 | 2024-04-11 | |
| Vultaggio Vincent | officer: Principal Accounting Officer | 2024-04-05 | 11.69 | 2024-04-11 | |
| Vultaggio Vincent | officer: Principal Accounting Officer | 2024-04-05 | 23.65 | 2024-04-11 | |
| Vultaggio Vincent | officer: Principal Accounting Officer | 2024-04-05 | 52.61 | 2024-04-11 | |
| Epperly Melissa B, | officer: Chief Financial Officer | 2024-02-12 | S-Sale | 11.44 | 2024-02-12 |
| Gallagher Cam | director, officer: President | 2024-02-12 | S-Sale | 11.44 | 2024-02-12 |
| HAUSMAN DIANA | officer: Chief Medical Officer | 2024-02-01 | A-Award | 0 | 2024-02-05 |
| HAUSMAN DIANA | officer: Chief Medical Officer | 2024-02-01 | A-Award | 11.69 | 2024-02-05 |
| Lackner Mark | officer: Chief Scientific Officer | 2024-02-01 | A-Award | 0 | 2024-02-05 |
| Lackner Mark | officer: Chief Scientific Officer | 2024-02-02 | S-Sale | 11.54 | 2024-02-05 |
| Lackner Mark | officer: Chief Scientific Officer | 2024-02-01 | A-Award | 11.69 | 2024-02-05 |
| Paul Andrea | officer: Chief Legal Officer | 2024-02-01 | A-Award | 0 | 2024-02-05 |
| Paul Andrea | officer: Chief Legal Officer | 2024-02-02 | S-Sale | 11.54 | 2024-02-05 |
| Paul Andrea | officer: Chief Legal Officer | 2024-02-01 | A-Award | 11.69 | 2024-02-05 |
| Paul Andrea | officer: Chief Legal Officer | 2024-02-01 | A-Award | 11.69 | 2024-02-05 |
| Gallagher Cam | director, officer: President | 2024-02-01 | A-Award | 0 | 2024-02-05 |
| Gallagher Cam | director, officer: President | 2024-02-02 | S-Sale | 11.54 | 2024-02-05 |
| Gallagher Cam | director, officer: President | 2024-02-01 | A-Award | 11.69 | 2024-02-05 |
| Epperly Melissa B, | officer: Chief Financial Officer | 2024-02-01 | A-Award | 0 | 2024-02-05 |
| Epperly Melissa B, | officer: Chief Financial Officer | 2024-02-02 | S-Sale | 11.54 | 2024-02-05 |
| Epperly Melissa B, | officer: Chief Financial Officer | 2024-02-01 | A-Award | 11.69 | 2024-02-05 |
| Blackwell Kimberly | director, officer: Chief Executive Officer | 2024-02-01 | A-Award | 0 | 2024-02-05 |
| Blackwell Kimberly | director, officer: Chief Executive Officer | 2024-02-01 | F-InKind | 11.69 | 2024-02-05 |
| Blackwell Kimberly | director, officer: Chief Executive Officer | 2024-02-01 | A-Award | 11.69 | 2024-02-05 |
| Lackner Mark | officer: Chief Scientific Officer | 2024-01-02 | A-Award | 15.99 | 2024-01-03 |
| Lackner Mark | officer: Chief Scientific Officer | 2024-01-02 | A-Award | 0 | 2024-01-03 |
| Lackner Mark | officer: Chief Scientific Officer | 2023-12-31 | 0 | 2024-01-03 | |
| Lackner Mark | officer: Chief Scientific Officer | 2023-12-31 | 25.6 | 2024-01-03 | |
| Lackner Mark | officer: Chief Scientific Officer | 2023-12-31 | 23.65 | 2024-01-03 | |
| Bunker Kevin D. | officer: Chief Scientific Officer | 2023-12-20 | G-Gift | 0 | 2023-12-21 |
| Johnson David Michael | director | 2023-11-10 | P-Purchase | 9.879 | 2023-11-13 |
| Blackwell Kimberly | director, officer: Chief Executive Officer | 2023-11-13 | P-Purchase | 10.2896 | 2023-11-13 |
| Brownstein Carrie | officer: Chief Medical Officer | 2023-10-04 | S-Sale | 19.4265 | 2023-10-06 |
| Brownstein Carrie | officer: Chief Medical Officer | 2023-10-04 | S-Sale | 19.9102 | 2023-10-06 |